BioLife Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . BioLife Solutions
BLFS Stock  USD 24.63  1.29  4.98%   
BioLife Solutions financial statements provide useful quarterly and yearly information to potential BioLife Solutions investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on BioLife Solutions financial statements helps investors assess BioLife Solutions' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting BioLife Solutions' valuation are summarized below:
Gross Profit
53.7 M
Profit Margin
(0.25)
Market Capitalization
1.2 B
Enterprise Value Revenue
13.3555
Revenue
82.3 M
There are over one hundred nineteen available fundamental signals for BioLife Solutions, which can be analyzed over time and compared to other ratios. All traders should validate BioLife Solutions' prevailing fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 1.3 B in 2025. Enterprise Value is likely to gain to about 1.2 B in 2025

BioLife Solutions Total Revenue

86.37 Million

Check BioLife Solutions financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioLife Solutions' main balance sheet or income statement drivers, such as Interest Expense of 755 K, Selling General Administrative of 38.5 M or Total Revenue of 86.4 M, as well as many indicators such as Price To Sales Ratio of 13.81, Dividend Yield of 0.0014 or PTB Ratio of 3.26. BioLife financial statements analysis is a perfect complement when working with BioLife Solutions Valuation or Volatility modules.
  
Check out the analysis of BioLife Solutions Correlation against competitors.
For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.

BioLife Solutions Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets419.5 M399.5 M166.6 M
Slightly volatile
Other Current Liabilities13 M12.3 M6.1 M
Slightly volatile
Total Current Liabilities34.4 M32.7 M14.3 M
Slightly volatile
Cash100.2 M95.4 M29.4 M
Slightly volatile
Non Currrent Assets Other11.7 M11.1 M3.7 M
Slightly volatile
Other Assets466.3 M444.1 M139.4 M
Slightly volatile
Cash And Short Term Investments109.8 M104.6 M34.4 M
Slightly volatile
Common Stock Shares Outstanding48.4 M46.1 M21.7 M
Slightly volatile
Other Current Assets3.7 M6 M6.7 M
Pretty Stable
Other Stockholder Equity366.4 M348.9 M225.3 M
Slightly volatile
Total Liabilities53.1 M50.6 M27.2 M
Slightly volatile
Total Current Assets156.2 M148.8 M56.6 M
Slightly volatile
Accounts Payable2.1 M3.6 M3.5 M
Slightly volatile
Non Current Liabilities Total18.7 M17.8 M12.9 M
Slightly volatile
Inventory30.5 M29 M12.5 M
Slightly volatile
Net Receivables9.6 M9.2 M7.5 M
Slightly volatile
Short and Long Term Debt Total14.2 M25.2 M20.8 M
Very volatile
Common Stock Total Equity35.1 K38 K29.1 K
Very volatile
Short Term Debt13.1 M12.5 M4.5 M
Slightly volatile
Common Stock36.6 K51.8 K32 K
Pretty Stable
Current Deferred Revenue97.8 K103 K350.4 K
Slightly volatile
Property Plant Equipment56.3 M53.6 M18.2 M
Slightly volatile
Other Liabilities2.8 M3 M8.8 M
Pretty Stable
Capital Surpluse365.4 M348 M166.1 M
Slightly volatile
Deferred Long Term Liabilities47.8 M45.5 M18.5 M
Slightly volatile
Non Current Liabilities Other2 M2.1 M5.1 M
Slightly volatile
Deferred Long Term Asset Charges146.1 K132.1 K121.1 K
Very volatile
Warrants1.1 M1.2 M1.3 M
Slightly volatile
Long Term Debt Total2.3 M2.6 M2.8 M
Slightly volatile
Long Term Investments4.9 M5.6 M3.6 M
Slightly volatile
Short and Long Term Debt11.5 M10.9 M3.4 M
Slightly volatile
Net Invested Capital262.4 M364.8 M140.1 M
Slightly volatile
Net Working Capital73.4 M116 M41.6 M
Slightly volatile
Capital Stock39.3 K47 K27.6 K
Slightly volatile
Capital Lease Obligations14.8 M14.2 M6.7 M
Slightly volatile

BioLife Solutions Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative38.5 M40.5 M16.9 M
Slightly volatile
Total Revenue86.4 M82.3 M46.1 M
Slightly volatile
Other Operating Expenses93.9 M89.4 M56.8 M
Slightly volatile
Cost Of Revenue25.7 M24.5 M24.7 M
Slightly volatile
Total Operating Expenses68.1 M64.9 M32.1 M
Slightly volatile
Research Development8.3 M7.9 M5.2 M
Slightly volatile
Selling And Marketing Expenses9.1 M9.6 M27.2 M
Slightly volatile
Interest Income63.4 K66.7 K80.1 K
Pretty Stable
Preferred Stock And Other Adjustments303.3 K389.9 K276.7 K
Slightly volatile
Reconciled Depreciation7.4 M8.7 M4 M
Slightly volatile
Non Recurring643.2 K601.2 K832.3 K
Slightly volatile

BioLife Solutions Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow37.2 M35.4 M19 M
Slightly volatile
End Period Cash Flow100.2 M95.4 M29 M
Slightly volatile
Stock Based Compensation19 M30.9 M22.1 M
Pretty Stable

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio13.8114.5391124
Slightly volatile
Dividend Yield0.00140.0020.0017
Slightly volatile
Days Sales Outstanding38.6540.682860.5319
Slightly volatile
Average Payables396.1 K630.8 K646.6 K
Very volatile
Stock Based Compensation To Revenue0.360.37590.1286
Slightly volatile
EV To Sales13.013.6856124
Slightly volatile
Inventory Turnover0.80.84453.5497
Slightly volatile
Days Of Inventory On Hand238432183
Slightly volatile
Payables Turnover3.586.85755.5466
Slightly volatile
Sales General And Administrative To Revenue0.470.49290.4514
Slightly volatile
Average Inventory2.2 M2.1 M1.6 M
Slightly volatile
Research And Ddevelopement To Revenue0.09140.09620.132
Slightly volatile
Capex To Revenue0.03730.03920.0812
Slightly volatile
Cash Per Share2.382.27031.1047
Slightly volatile
Days Payables Outstanding50.5653.226170.3143
Slightly volatile
Intangibles To Total Assets0.320.55540.4064
Slightly volatile
Current Ratio3.324.54454.7973
Pretty Stable
Receivables Turnover8.158.97196.8386
Pretty Stable
Capex Per Share0.120.07010.1044
Slightly volatile
Average Receivables1.9 M1.8 M1.5 M
Slightly volatile
Revenue Per Share1.641.78551.5079
Slightly volatile
Interest Debt Per Share0.510.54650.7074
Pretty Stable
Debt To Assets0.05990.0630.8842
Slightly volatile
Graham Number3.983.663.9036
Slightly volatile
Operating Cycle325473236
Slightly volatile
Days Of Payables Outstanding50.5653.226170.3143
Slightly volatile
Quick Ratio3.733.65823.9725
Pretty Stable
Cash Ratio1.712.9143.6002
Pretty Stable
Days Of Inventory Outstanding238432183
Slightly volatile
Days Of Sales Outstanding38.6540.682860.5319
Slightly volatile
Fixed Asset Turnover4.864.90835.4506
Very volatile
Debt Ratio0.05990.0630.8842
Slightly volatile
Price Sales Ratio13.8114.5391124
Slightly volatile
Asset Turnover0.20.20590.7143
Slightly volatile
Gross Profit Margin0.410.70210.4895
Pretty Stable

BioLife Solutions Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.3 B1.2 B470.6 M
Slightly volatile
Enterprise Value1.2 B1.1 B452.8 M
Slightly volatile

BioLife Fundamental Market Drivers

Forward Price Earnings250
Cash And Short Term Investments104.6 M

BioLife Upcoming Events

21st of March 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
21st of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About BioLife Solutions Financial Statements

BioLife Solutions shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although BioLife Solutions investors may analyze each financial statement separately, they are all interrelated. The changes in BioLife Solutions' assets and liabilities, for example, are also reflected in the revenues and expenses on on BioLife Solutions' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue103 K97.8 K
Total Revenue82.3 M86.4 M
Cost Of Revenue24.5 M25.7 M
Stock Based Compensation To Revenue 0.38  0.36 
Sales General And Administrative To Revenue 0.49  0.47 
Research And Ddevelopement To Revenue 0.10  0.09 
Capex To Revenue 0.04  0.04 
Revenue Per Share 1.79  1.64 
Ebit Per Revenue(0.09)(0.09)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for BioLife Stock Analysis

When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY